Plant ID: NPO33321
Plant Latin Name: aristolochia constricta
Taxonomy Genus: Aristolochia
Taxonomy Family: Aristolochiaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
92853-1
Brazil; Honduras; Peru; Venezuela; Costa Rica; Colombia; Bolivia; Nicaragua; Ecuador
SLC6A3; SLC6A2; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
SLC superfamily of solute carriers | SLC6A3 | Dopamine transporter | Q01959 | CHEMBL238 |
SLC superfamily of solute carriers | SLC6A2 | Norepinephrine transporter | P23975 | CHEMBL222 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0023052; signaling | GO:0051583; dopamine uptake involved in synaptic transmission | 4.823E-07 | 1.750E-03 | SLC6A2, SLC6A3 |
MF | GO:0005215; transporter activity | GO:0005330; dopamine:sodium symporter activity | 9.649E-08 | 1.750E-03 | SLC6A2, SLC6A3 |
MF | GO:0005215; transporter activity | GO:0005328; neurotransmitter:sodium symporter activity | 6.104E-06 | 1.108E-02 | SLC6A2, SLC6A3 |
CC | GO:0016020; membrane | GO:0045121; membrane raft | 1.348E-03 | 5.314E-01 | SLC6A2, SLC6A3 |
CC | GO:0044464; cell part | GO:0043005; neuron projection | 9.604E-03 | 1.000E+00 | SLC6A2, SLC6A3 |
CC | GO:0044425; membrane part | GO:0005887; integral component of plasma membrane | 2.889E-02 | 1.000E+00 | SLC6A2, SLC6A3 |
CC | GO:0044456; synapse part | GO:0098793; presynapse | 3.394E-02 | 1.000E+00 | SLC6A3 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 5.788E-03 | 2.259E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 9.169E-03 | 2.259E-02 | CYP3A4 |
09160 Human Diseases | 09164 Substance dependence | hsa05030 | Cocaine addiction | 9.765E-03 | 2.259E-02 | SLC6A3 |
09160 Human Diseases | 09164 Substance dependence | hsa05031 | Amphetamine addiction | 1.333E-02 | 2.259E-02 | SLC6A3 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.155E-02 | 2.259E-02 | CYP3A4 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.294E-02 | 2.259E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.373E-02 | 2.259E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.452E-02 | 2.259E-02 | CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.413E-02 | 2.259E-02 | CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.630E-02 | 2.282E-02 | CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|